[ad_1]
ATLANTA, Ga., July 8, 2019 / PRNewswire / – Intent Solutions, a solution Atlantagrbadroots company that provides technology to improve the safety and compliance of prescription drugs, today announced its partnership with University of Kentucky in one $ 15 million federal subsidy program aimed at eliminating hepatitis C in an is Kentucky county hardest hit by the disease.
Intent Solutions recently signed a contract with the University of Kentucky manage the distribution of hepatitis C drugs to 900 participants in the program and use the gender™ dispensing system to track patient adherence to the prescribed medication regimen. The study on the treatment of viral hepatitis in Kentucky (KeY Treat) aims to eliminate the hepatitis C virus (HCV) from County Perry treating all residents of the country who have a chronic infection, especially those who are at greatest risk of transmitting the virus.
The program is funded by the National Cancer Institute and the National Institute on Drug Abuse.
"A bit is particularly suited to population health intervention programs like this one, and we are proud to be part of it," he said. Sam Zamarripa, CEO of Intent Solutions. "Although our drug system was originally developed to reduce misuse, abuse and diversion of opioids, we also found its potential in other areas, such as clinical trials.In the treatment of hepatitis C, it is essential that the drugs be well taken.Remove the body of the hepatitis C virus (HCV), and it is a ideal tool to achieve this, as leaders of Kentucky intervention program in this Appalachian county clearly see ".
Monitor membership for the program to reach its goals
An acronym for the timeless warning of "take as directed", tad is an automated dispensing device the size of a smartphone. Containing a reserve of pills that can go up to 30 days, simply press a finger on its biometric keyboard to administer the correct daily or periodic dosage. Setting a new standard for monitoring and managing drug adherence, it informs doctors, therapists and caregivers not only of the frequency with which patients take their medications, but also of any attempt to treat them. Abuse, misuse or misuse drugs for the purpose for which they are intended.
"Compliance is important in any treatment program, but especially in the 12-week regimen required to rid the body of the hepatitis C virus (HCV)," Zamarripa said. "This will increase the chances of survival for these people.Our technology provides us with a new level of safety and security that prescription drugs have never been available – and a new level of integrity of data on compliance. "
Their ability to determine if medications are taken correctly is especially important for a program like this. Biopharmaceutical company Gilead Sciences donated drugs for use, worth approximately $ 20 million.
"By taking the medications as prescribed, the likelihood of being cured is extremely high," he said. Jennifer Havens, principal investigator for KeY Treat. "This allows us to clearly know if people are taking their medications well, or we can intervene quickly to prevent waste and misuse, and to ensure that the goals of the study are achieved."
Well suited for hepatitis C programs
the Kentucky program targets HIV-positive people for HCV County Perry, one of the rural American communities that has experienced an outbreak of HCV largely as a result of the opioid crisis. Havens estimates that at least half of sufferers suffer from or already have a disorder related to the use of opioids, one of the leading causes of HCV infection. the $ 15 million for the program will also include support for the county needle exchange program, access to drug treatment of opioid consumption disorder and badistance with housing and unemployment.
Since a drug is now available to treat people infected with HCV, the World Health Organization has set a goal of eliminating the virus as a health threat. public by 2030.
"Some of the people involved in the HCV elimination work feel that micro-elimination is the best way to achieve the goal, that is, to treat people belonging to the community. to smaller and more targeted groups, such as the inhabitants of County Perry, "Said Zamarripa." This is one of the reasons why participating in the program is so exciting for us. We hope this program will be used in other programs intended for specific population segments with infections that can be treated with prescription drugs. "
And since HCV infection is widespread among opioid addicts, Zamarripa believes that projects like Kentucky They fit well into the company's original mission of providing a solution to the opioid crisis.
"This mission found its instrument through the invention of Intent Solutions aimed at controlling how pharmacists deliver opioids and preventing people from becoming addicted," he said. "But we are now seeing that we can fight drug addiction on a new front, helping people with an infection that would be a highly likely consequence of opioid addiction." It's gratifying for us to make progress in this area. this new area and see how our solution is well suited to these new challenges. "
The US Department of Health and Human Services reports that more than 3 million Americans live with hepatitis C and that most do not feel sick or do not know that they are infected. For many, the infection can eventually lead to cirrhosis, liver cancer or death. More than 12,000 people die each year in the United States from a hepatitis C-related illness that kills more Americans than any other infectious disease. Although there is currently a cure for HCV infection, there is no vaccine as exists for hepatitis A and B.
About the solutions of intention
Intent Solutions is a AtlantaTechnology, software and data company based on information technologies, whose mission is to use technologies to reduce misuse, abuse and misappropriation of technology. 39; opioids and other prescription drugs and to improve medication safety and compliance. The tad of the companyTM The dispenser and the software application provide an attractive environment in which prescriptions can be met and the daily dosage monitored and managed. Led by a management team with extensive experience in health technologies and civic leadership, Intent Solutions is committed to helping resolve the opioid crisis and other health issues of the population through to innovation and a working partnership with governments, health care and the pharmaceutical industry.
Media contact
Jenn Pratt
[email protected]
Cell: (404) 655-2273
SOURCE Intention Solutions
Related Links
http://www.intentsolutions.com/
Source link
